Rankings
▼
Calendar
BDTX Q2 2023 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
BDTX
Black Diamond Therapeutics, Inc.
$126M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$20M
Net Income
-$19M
EPS (Diluted)
$-0.52
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$120M
Total Liabilities
$38M
Stockholders' Equity
$82M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$20M
-$23M
+13.6%
Net Income
-$19M
-$23M
+16.5%
← FY 2023
All Quarters
Q3 2023 →